Resident 360 Study Plans on AMBOSS

Find all Resident 360 study plans on AMBOSS

Fast Facts

A brief refresher with useful tables, figures, and research summaries

Medication Management

In the United States, nearly 50% of people older than age 65 take at least five prescription drugs per day. In these older adults, simultaneous use of multiple drugs (polypharmacy) can affect medication adherence, lead to poor health outcomes, and put patients at risk for falls, behavioral changes, and other geriatric syndromes. Prescribers should be vigilant for physiological changes in older adults that can affect how the body handles drugs (pharmacokinetics) and how drugs affect the body (pharmacodynamics).

According to a surveillance study using 2007-2009 data from a nationally representative sample of 58 hospitals, the following four medications accounted for more than two-thirds of nearly 100,000 emergency hospitalizations for adverse drug events annually in U.S. adults aged 65 or older:

  • warfarin (33%)

  • insulin (14%)

  • oral antiplatelet agents (13%)

  • oral hypoglycemic agents (11%)

The figure below, taken from that study, shows estimated hospitalization rates related to outpatient use of various categories of medications.

Estimated Rates of Hospitalization Due to Implicated Drugs
[Image]

(Source: Emergency Hospitalizations for Adverse Drug Events in Older Americans. N Engl J Med 2011.)

Prescribing in Older Adults

Patients may not report all medications they are currently taking, particularly herbal supplements. Asking patients to bring all medications and supplements to the office visit can help with medication reconciliation accuracy.

The risk of drug-related adverse events, including adverse events related to dosing or drug-drug interactions, increases with the number of medications prescribed to treat comorbidities. This risk can be reduced by regularly reviewing medications and discontinuing those for which the risks outweigh the benefits and those that lack a clear indication for use in a particular patient. For certain classes of medications, tapering is necessary to prevent withdrawal.

A number of tools, such as the evidence-based Screening Tool of Older People's Prescriptions (STOPP) criteria and the American Geriatrics Society 2019 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, can be used to identify drugs associated with high risk of adverse events in older adults. Medications should be discontinued for the following reasons:

  • the indication for the drug no longer exists

  • the benefit of the medication is unlikely to be commensurate with the patient’s life expectancy

  • the drug causes adverse reactions the patient is nonadherent

Examples of Common Drug Classes to Avoid in Older Adults According to the Beers Criteria
Drug Class Rationale
Anticholinergic drugs* Increased risk of confusion
Peripheral alpha-1 blockers (for treatment of hypertension) Increased risk of orthostatic hypotension, dizziness
Benzodiazepines, nonbenzodiazepine hypnotics, and skeletal muscle relaxants Sedating
Barbiturates Sedating; risk for overdose and dependence
Proton pump inhibitors (PPIs) Increased risk of Clostridium difficile infection with prolonged use and increased risk of fracture (secondary to decreased calcium absorption)
Long-acting sulfonylureas (glyburide, glimepiride), sliding-scale insulin Increased risk of hypoglycemia
Nonsteroidal anti-inflammatory drugs (NSAIDs) Increased risk of gastrointestinal ulceration and kidney injury

Research

Landmark clinical trials and other important studies

Research

Development of a Metric To Detect and Decrease Low-Value Prescribing in Older Adults

Radomski TR et al. JAMA Netw Open 2022.

The authors identified 18 prescribing practices to detect low-value prescribing in older adults.

[Image]
The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial

McDonald EG et al. JAMA Intern Med 2022.

Hospital clinical decision support to aid in deprescribing did not result in a change in 30-day postdischarge adverse drug events in older adults.

Read the NEJM Journal Watch Summary

[Image]
A Multidimensional Measure of Polypharmacy for Older Adults Using the Health and Retirement Study

Carr E et al. Sci Rep 2021.

These authors developed a multidimensional measurement of polypharmacy that differentiated individuals in terms of aking risk profile and temporality of medication taking.

[Image]
Potentially Inappropriate Prescribing and Its Associations With Health-Related and System-Related Outcomes in Hospitalised Older Adults: A Systematic Review and Meta-Analysis

Mekonnen AB et al. Br J Clin Pharmacol 2021.

Potentially inappropriate prescribing was associated with increased odds of an admission due to adverse drug events, functional decline, adverse drug events/reactions, falls, but was not associated with all-cause mortality or readmission.

[Image]
Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness: A Randomized Clinical Trial

Kutner JS et al. JAMA Intern Med 2015.

A trial that examined mortality and morbidity outcomes with statin therapy discontinuation in older adults with advanced diseases.

[Image]

Reviews

The best overviews of the literature on this topic

Reviews

[Image]
Medication Management in Older Adults

Kim LD et al. Cleve Clin J Med 2018.

[Image]
[Image]
[Image]
[Image]
[Image]
Principles of Conservative Prescribing

Schiff GD et al. Arch Intern Med 2011.

[Image]

Guidelines

The current guidelines from the major specialty associations in the field

Guidelines

American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

2019 American Geriatrics Society Beers Criteria® Update Expert Panel. J Am Geriatr Soc 2019.

[Image]
[Image]